Skip to main content
OpenTrials
Completed

NCT Number: NCT01576081

The Novel Unloading Device "HEPHAISTOS" and Its Effects Upon Bone, Muscle and Vasculature

The present study aimed to investigate the importance of gravitational induced forces that appear during normal ambulation for the health of muscles, bones and blood vessels. The main hypothesis of the present study is that gravitational loading alone, without muscle contractions, is insufficient to maintain bone strength.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–40 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

German Aerospace Center

Cologne, 51147, Germany

About this study

The 56day unloading intervention with HEPHAISTOS had the following key objectives:

  • Primary objective: Assessment and evaluation of bone adaptation.
  • Secondary objective: Assessment and evaluation of functional and structural muscular adaptations.
  • Third objective: Assessment and evaluation of functional and structural vascular adaptations.
  • Fourth objective: Assessment and evaluation if the present findings deviate from findings observed in established unloading models.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • male
  • age: 20-40 years
  • BMI: 20-30
  • passing the psychological and medical check up.
  • signed consent to participate in the study
  • faultless certificate of good conduct

Exclusion criteria

  • smoking
  • professional athletes
  • diabetes
  • muscle or joint disease
  • trabecular bone density in the distal tibia epiphysis < 160mg/cm3
  • increase risk of thrombosis
  • bone fractures 12 months prior to the study
  • metal implants, any material of osteosynthesis
  • participation in another clinical intervention study 2 months prior to the study
  • bleeding disorder
  • anesthetic intolerance
  • vascular disease
  • epilepsy
  • claustrophobia
  • herniated disk
  • pacemaker
  • alcohol or drug abuse
  • anti-inflammatory drug intake during the study
  • hyperlipidemia
  • kidney disease
  • hyperhomocysteinaemia
  • vitamin d deficit
  • chronical back pain
  • detained

Treatment and study plan

HEPHAISTOS

Device

HEPHAISTOS unloading orthotic

Primary outcomes

  1. Bone density as measured with pQCT

    Time frame: 1 year

    subjects will be followed for one year, starting from the onset of the study

Sponsors and collaborators

Lead sponsor

DLR German Aerospace Center

Other

Registry information

Official study title

The Effects of a 56day Unilateral Muscular Unloading Intervention With a Novel Device That Allows Normal Ambulation While Reducing Muscle Activation Drastically, on Muscles, Bones and Vessels.

Acronym: HEP

Important dates

Study start
2011
Primary completion
2012
Study completion
2012
First posted
Apr 12, 2012
Registry last updated
Aug 16, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.